A Randomized, Open Label Phase 1 Study in Healthy Participants to Evaluate the Relative Bioavailability of a Single Dose of Various Test Solid Formulations of TAK-020 Compared With a Single Dose of Reference Oral Solution and to Evaluate the Food Effect and Potentially the Dose Proportionality of the Optimal Solid Dose Formulation

Trial Profile

A Randomized, Open Label Phase 1 Study in Healthy Participants to Evaluate the Relative Bioavailability of a Single Dose of Various Test Solid Formulations of TAK-020 Compared With a Single Dose of Reference Oral Solution and to Evaluate the Food Effect and Potentially the Dose Proportionality of the Optimal Solid Dose Formulation

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Oct 2016

At a glance

  • Drugs TAK 020 (Primary) ; TAK 020
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Takeda
  • Most Recent Events

    • 07 Sep 2016 Status changed from recruiting to completed.
    • 01 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 01 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top